Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 24, 2006
Association between functional FABP2 promoter haplotype and type 2 diabetesY Li, E Fisher, M Klapper, et al.Gut|August 13, 2002
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel diseaseS Schreiber, P Rosenstiel, J Hampe, et al.Genes and Immunity|February 16, 2007
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitisT H Karlsen, K M Boberg, M Vatn, et al.Journal of Crohn'S & Colitis|February 8, 2018
Microbial Spectrum of Intra-Abdominal Abscesses in Perforating Crohn's Disease: Results from a Prospective German RegistryP A Reuken, W Kruis, C Maaser, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 26, 2014
Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome studyC Hauser, C Patett, W von Schoenfels, et al.Alimentary Pharmacology & Therapeutics|December 22, 2017
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitisF Bär, T Kühbacher, N A Dietrich, et al.Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.Gut|January 13, 2001
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel diseaseJ Hampe, N J Lynch, S Daniels, et al.Annals of Human Genetics|August 28, 2003
Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex diseaseS A Fisher, A Moody, M M Mirza, et al.European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.Pageof 7